Reply to 'Is Liver Resection in Metastases of Exocrine Pancreatic Carcinoma Justified?'

Authors

  • Amanjeet Singh Department of Surgical Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar. New Delhi, India
  • Tanveer Singh Department of Surgical Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar. New Delhi, India
  • Adarsh Chaudhary Department of Surgical Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar. New Delhi, India

DOI:

https://doi.org/10.6092/1590-8577/3392

Keywords:

Chemotherapy, Adjuvant, Neoplasm Metastasis, Pancreatic Neoplasms

Abstract

No abstract available.

Image: Rai Bahadur Ganga Ram.

Downloads

Download data is not yet available.

References

Saif MW. Is liver resection in metastases of exocrine pancreatic carcinoma justified? JOP. J Pancreas (Online) 2011; 12:68-9.

Kleeff J, Friess H, Buchler MW. Neoadjuvant therapy for pancreatic cancer. Br J Surg 2007; 94:261-2. [PMID 17315287]

Reni M. Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing? World J Gastroenterol 2010; 16:4883-7. [PMID 20954273]

Rai Bahadur Ganga Ram

Downloads

Published

2011-01-05

How to Cite

Singh, A., Singh, T., & Chaudhary, A. (2011). Reply to ’Is Liver Resection in Metastases of Exocrine Pancreatic Carcinoma Justified?’. JOP. Journal of the Pancreas, 12(1), 71. https://doi.org/10.6092/1590-8577/3392

Issue

Vol. 12 No. 1 (2011): January - p. 1-77

Section

REPLY

License

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.